Document is current

Article History

First Online: 10 October 2019

Compliance with Ethical Standards

:

: The authors of this publication were supported by the National Institutes of Health through Grant Numbers R01FD006108 (Yvonne M. Saenger) and KL2TR001874 (Robyn D. Gartrell-Corrado). Yvonne M. Saenger is also supported by funding from the Melanoma Research Alliance and by an Irving Assistant Professorship at Columbia University’s NIH/NCATS CTSA Program hub: UL1TR001873. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Robyn D. Gartrell-Corrado is also supported by Swim Across America. Megan H. Trager is supported by the Dean’s Research Fellowship at Columbia. Angelina M. Seffens is supported by the Howard Hughes Medical Institute Medical Student Fellowship. The funding sources had no role in the preparation of the manuscript or the decision to submit for publication.

: Emanuelle M. Rizk, Angelina M. Seffens, Megan H. Trager, and Michael R. Moore have no conflicts of interest that are directly relevant to the content of this article. Emanuelle M. Rizk received travel funding to a conference from nanoString. Yvonne M. Saenger receives funding from Amgen and Regeneron. Robyn D. Gartrell-Corrado receives funding from nanoString and travel support and honoraria from Northwest Biotherapeutics and PerkinElmer. Larisa J. Geskin receives funding, honoraria, travel support, and royalties from Helsinn, Mallincrodt, Kyowa Kirin, Medivir, Medscape, and UpToDate. Larisa J. Geskin has also provided expert testimony to Medivir. None of these funding sources have impacted the content of this article.